Treprostinil Palmitil Inhalation Powder

Phase 3

55%

Phase 3

Development Phase

1

Upcoming Catalysts

0

Historical Events

0

Regulatory Approvals

Upcoming Catalysts

Mar 14

INSM⭐Phase 3Phase 3

Treprostinil Palmitil Inhalation Powder Phase 3 Results Expected

Treprostinil Palmitil Inhalation Powder • Pulmonary Hypertension

Drug Information

Target Indication

Pulmonary Hypertension

Clinical Trial

Last updated: 12/4/2025

Developer

INSM

Insmed Incorporated